insight broker
broker organ revenu held well grow
materi affect howev revenu like pressur
start busi canceled/def model msd-hsd declin
pressur eas result declin busi
improv expect snap back pre-covid level highlight
solid result ep ahead consensu despit modestli higher
tax rate organ growth increas larg consist expect though
start dampen result particularli retir data analyt
meanwhil oper margin expand impress management start
 ep chang start experi headwind
coronaviru effect like show two aforement
segment revenu non-discretionari renew rate
adjust previou disclosur reflect disrupt risk
relat discretionari spend risk deferr never materi
model organ declin year reduc ep
management endeavor reduc expens enough absorb earn pressur
strong result ep beat consensu driven better expect
organ growth vs street margin expans revenu growth
well balanc ri mercer
 ep chang acknowledg low visibl management best
estim organ growth modestli ep consist
slightli better trend appli pressur consult
revenu margin believ ri defens still modestli
grow expand margin overal model organ declin year
reduc ep
strong result ep beat consensu organ growth
line us includ segment increas oper margin
flat yoy increas exclud unfavor mix tranzact
acquisit margin soft spot crb yoy declin irr
continu page
pleas see analyst certif import disclosur inform inform regard statu non-u analyst
page report
summari chang
pleas see import disclosur inform page report
 ep chang experienc coronaviru impact yet
brace slowdown given econom impact think hcb
busi would risk compani pull guidanc given fluid environ
management proactiv reduc discretionari spend help absorb potenti slowdown
organ growth view extrem downsid case double-digit declin later
year reduc ep year reflect buy-back
suspens impact lower revenu outlook
valuation/risk pt reflect price-to-earnings multipl
market multipl reflect defens model risk recess reduc demand
consult broke margin pressur close acquisit
valuation/risk use combin price-to-earnings ep dcf valuat
support pt risk recess reduc demand consult
broke sever price pressur deterior reinsur market
valuation/risk pt reflect price-to-earnings multipl peg
all-stock acquisit assum ntm base case pt risk
recess reduc demand consult broke margin pressur
close acquisit
pleas see import disclosur inform page report
pleas see import disclosur inform page report
report end thousand except gener oper income- incom net non-control net incom discontinu adjust net dilut share oper sizecompens bpsinform bpsamort bpsother gener bpsoper bpspre-tax bpstax bpsnet incom discontinu bpsadjust net bpsadjust oper bpssegment financialsseg revenu commerci risk analyt organ growth commerci risk bpsreinsur bpsretir bp bpsdata analyt bpsaon earn summaryreportedpercentag changediffer actual vs expect result
pleas see import disclosur inform page report
report end million except oper oper net benefit loss incom continu oper net incom attribut non-control net incom discontinu oper income- net adjust net dilut share oper sizecompens bpsother oper bpsoper bpspre-tax bpstax bpsnet bpsadjust net bpsadjust oper bpssegment financialsrisk insur servicestot bpsadjust oper bpsconsultingtot bpsadjust oper bpsunalloc adjust oper organ bpsmarsh mclennan compani earn summaryreportedpercentag changediffer summari actual vs estim
pleas see import disclosur inform page report
report thousand except statementtot oper integr oper incom expens incom incom incom interest earn gaap net dilut item net non-gaap net dilut share oper sizeadjust oper bpstax bpsnon-gaap net bpsadjust bpssegment financialshuman capit benefitscommiss bpsorgan commiss fee bpscorpor risk brokingcommiss bpsorgan commiss fee bpsinvest risk reinsurancecommiss bpsorgan commiss fee bpsbenefit deliveri administrationcommiss bpsorgan commiss fee bpstotal global commiss fee organ bpswilli tower earn summaryreportedpercentag changediffer equiti research
pleas see import disclosur inform page report
pleas see import disclosur inform page report
pleas see import disclosur inform page report
organ revenu declin lsd year rise
lsd
oper margin expand lt
paus buyback resum
organ growth lsd
strong histori manag execut
take share competitor merg
pleas see import disclosur inform page report
organ revenu declin lsd rebound
lsd increas
suspens buyback
organ growth lsd
organ declin hsd
custom eros jlt acquisit
strong deep manag team excel
track record execut
stabl busi consist organ growth larg
track gdp normal econom time
abil drive margin higher year year
strong balanc sheet capit deploy flexibl
organ growth benefit aon/wltw merger
pleas see import disclosur inform page report
organ revenu declin lsd rebound
lsd increas
suspens buyback
takeout expect close earli
price peg stock acquisit
base ntm pt base case
revenu growth
price peg stock acquisit
base ntm pt upsid case
revenu growth
oper margin expand
demand discretionari project slow
price peg stock acquisit
base ntm pt downsid case
organ growth improv msd make
increas capit deploy flexibl
close acquisit
pleas see import disclosur inform page report
